Cargando…

The Willingness to get Vaccinated Against SARS-CoV-2 Virus among Southeast Asian Countries: Does the Vaccine Brand Matter?

The current study uses data surveyed with 2,500 respondents during August and September 2021 in Vietnam, Indonesia, the Philippines and Malaysia to examine the willingness to get vaccinated against SARS-CoV-2 virus with six COVID-19 vaccines. The willingness to get vaccinated varies according to the...

Descripción completa

Detalles Bibliográficos
Autores principales: Duong, An Hoai, Antriyandarti, Ernoiz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472728/
https://www.ncbi.nlm.nih.gov/pubmed/36124083
http://dx.doi.org/10.1007/s11482-022-10104-5
_version_ 1784789357109968896
author Duong, An Hoai
Antriyandarti, Ernoiz
author_facet Duong, An Hoai
Antriyandarti, Ernoiz
author_sort Duong, An Hoai
collection PubMed
description The current study uses data surveyed with 2,500 respondents during August and September 2021 in Vietnam, Indonesia, the Philippines and Malaysia to examine the willingness to get vaccinated against SARS-CoV-2 virus with six COVID-19 vaccines. The willingness to get vaccinated varies according to the vaccine brands and selected influential factors. Particularly, the percentage of respondents who are willing to get vaccinated with Pfizer, Moderna and AstraZeneca dominates that of those who are willing to get vaccinated with Sinopharm, Janssen and Sputnik V vaccines. Results generated from the binary logistic regressions show that the impact of the selected influential factors on the willingness to get vaccinated varies in terms of magnitude and direction, and depending on the vaccine brands. The results indicate that additional scientific evidence on the efficacy and safety of the vaccines is essential for the respondents to decide whether to vaccinate or not. Such evidence can be made available in multiple formats and provided through appropriate channels and vaccination communication campaigns.
format Online
Article
Text
id pubmed-9472728
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-94727282022-09-15 The Willingness to get Vaccinated Against SARS-CoV-2 Virus among Southeast Asian Countries: Does the Vaccine Brand Matter? Duong, An Hoai Antriyandarti, Ernoiz Appl Res Qual Life Article The current study uses data surveyed with 2,500 respondents during August and September 2021 in Vietnam, Indonesia, the Philippines and Malaysia to examine the willingness to get vaccinated against SARS-CoV-2 virus with six COVID-19 vaccines. The willingness to get vaccinated varies according to the vaccine brands and selected influential factors. Particularly, the percentage of respondents who are willing to get vaccinated with Pfizer, Moderna and AstraZeneca dominates that of those who are willing to get vaccinated with Sinopharm, Janssen and Sputnik V vaccines. Results generated from the binary logistic regressions show that the impact of the selected influential factors on the willingness to get vaccinated varies in terms of magnitude and direction, and depending on the vaccine brands. The results indicate that additional scientific evidence on the efficacy and safety of the vaccines is essential for the respondents to decide whether to vaccinate or not. Such evidence can be made available in multiple formats and provided through appropriate channels and vaccination communication campaigns. Springer Netherlands 2022-09-14 2023 /pmc/articles/PMC9472728/ /pubmed/36124083 http://dx.doi.org/10.1007/s11482-022-10104-5 Text en © The International Society for Quality-of-Life Studies (ISQOLS) and Springer Nature B.V. 2022, Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Duong, An Hoai
Antriyandarti, Ernoiz
The Willingness to get Vaccinated Against SARS-CoV-2 Virus among Southeast Asian Countries: Does the Vaccine Brand Matter?
title The Willingness to get Vaccinated Against SARS-CoV-2 Virus among Southeast Asian Countries: Does the Vaccine Brand Matter?
title_full The Willingness to get Vaccinated Against SARS-CoV-2 Virus among Southeast Asian Countries: Does the Vaccine Brand Matter?
title_fullStr The Willingness to get Vaccinated Against SARS-CoV-2 Virus among Southeast Asian Countries: Does the Vaccine Brand Matter?
title_full_unstemmed The Willingness to get Vaccinated Against SARS-CoV-2 Virus among Southeast Asian Countries: Does the Vaccine Brand Matter?
title_short The Willingness to get Vaccinated Against SARS-CoV-2 Virus among Southeast Asian Countries: Does the Vaccine Brand Matter?
title_sort willingness to get vaccinated against sars-cov-2 virus among southeast asian countries: does the vaccine brand matter?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472728/
https://www.ncbi.nlm.nih.gov/pubmed/36124083
http://dx.doi.org/10.1007/s11482-022-10104-5
work_keys_str_mv AT duonganhoai thewillingnesstogetvaccinatedagainstsarscov2virusamongsoutheastasiancountriesdoesthevaccinebrandmatter
AT antriyandartiernoiz thewillingnesstogetvaccinatedagainstsarscov2virusamongsoutheastasiancountriesdoesthevaccinebrandmatter
AT duonganhoai willingnesstogetvaccinatedagainstsarscov2virusamongsoutheastasiancountriesdoesthevaccinebrandmatter
AT antriyandartiernoiz willingnesstogetvaccinatedagainstsarscov2virusamongsoutheastasiancountriesdoesthevaccinebrandmatter